Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 7;222(7):e20231882.
doi: 10.1084/jem.20231882. Epub 2025 May 27.

IRF7 controls spontaneous autoimmune germinal center and plasma cell checkpoints

Affiliations

IRF7 controls spontaneous autoimmune germinal center and plasma cell checkpoints

Adam J Fike et al. J Exp Med. .

Abstract

How IRF7 promotes autoimmune B cell responses and systemic autoimmunity is unclear. Analysis of spontaneous SLE-prone mice deficient in IRF7 uncovered the IRF7 role in regulating autoimmune germinal center (GC), plasma cell (PC), and autoantibody responses and disease. IRF7, however, was dispensable for foreign antigen-driven GC, PC, and antibody responses. Competitive bone marrow (BM) chimeras highlighted the importance of IRF7 in hematopoietic cells in spontaneous GC and PC differentiation. Single-cell RNAseq of SLE-prone B cells indicated IRF7-mediated B cell differentiation through GC and PC fates. Mechanistic studies revealed that IRF7 promoted B cell differentiation through GC and PC fates by regulating the transcriptome, translation, and metabolism of SLE-prone B cells. Mixed BM chimeras demonstrated a requirement for B cell-intrinsic IRF7 in IgG autoantibody production but not in the regulation of spontaneous GC and PC responses. Altogether, we delineate previously unknown B cell-intrinsic and -extrinsic mechanisms of IRF7-promoted spontaneous GC and PC responses, loss of tolerance, autoantibody production, and SLE development.

PubMed Disclaimer

Conflict of interest statement

Disclosures: The authors declare no competing interests exist.

Update of

References

    1. Andrilenas, K.K., Ramlall V., Kurland J., Leung B., Harbaugh A.G., and Siggers T.. 2018. DNA-Binding landscape of IRF3, IRF5 and IRF7 dimers: Implications for dimer-specific gene regulation. Nucleic Acids Res. 46:2509–2520. 10.1093/nar/gky002 - DOI - PMC - PubMed
    1. Arkatkar, T., Du S.W., Jacobs H.M., Dam E.M., Hou B., Buckner J.H., Rawlings D.J., and Jackson S.W.. 2017. B cell-derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity. J. Exp. Med. 214:3207–3217. 10.1084/jem.20170580 - DOI - PMC - PubMed
    1. Bagavant, H., and Fu S.M.. 2009. Pathogenesis of kidney disease in systemic lupus erythematosus. Curr. Opin. Rheumatol. 21:489–494. 10.1097/BOR.0b013e32832efff1 - DOI - PMC - PubMed
    1. Ban, T., Kikuchi M., Sato G.R., Manabe A., Tagata N., Harita K., Nishiyama A., Nishimura K., Yoshimi R., Kirino Y., et al. 2021. Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease. Nat. Commun. 12:4379. 10.1038/s41467-021-24609-4 - DOI - PMC - PubMed
    1. Banga, J., Srinivasan D., Sun C.C., Thompson C.D., Milletti F., Huang K.S., Hamilton S., Song S., Hoffman A.F., Qin Y.G., et al. 2020. Inhibition of IRF5 cellular activity with cell-penetrating peptides that target homodimerization. Sci. Adv. 6:eaay1057. 10.1126/sciadv.aay1057 - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources